Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Chow

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
The Journal of Pathology|July 21, 2020
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumoursDawn R Cochrane, Kieran R Campbell, Kendall Greening, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2013
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortiumMartin Köbel, Steve E Kalloger, Sandra Lee, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Journal of Cardiac Failure|February 19, 2025
Characteristics and Outcomes of Patients With Cardiogenic Shock and Clinically Significant Valvular Heart Disease: From the Critical Care Cardiology Trials NetworkAnthony P Carnicelli, P Elliott Miller, David D Berg, et al.
The New England Journal of Medicine|October 15, 2010
ARID1A mutations in endometriosis-associated ovarian carcinomasKimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Neoplasia (New York, N.Y.)|September 18, 2025
Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomasDawn R Cochrane, Gian Luca Negri, Jutta Huvila, et al.
The Journal of Pathology|July 31, 2024
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinomaRodrigo Vallejos, Almira Zhantuyakova, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
The Journal of Pathology|July 21, 2020
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumoursDawn R Cochrane, Kieran R Campbell, Kendall Greening, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2013
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortiumMartin Köbel, Steve E Kalloger, Sandra Lee, et al.
The New England Journal of Medicine|December 23, 2011
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancersAlireza Heravi-Moussavi, Michael S Anglesio, S-W Grace Cheng, et al.
Journal of Cardiac Failure|February 19, 2025
Characteristics and Outcomes of Patients With Cardiogenic Shock and Clinically Significant Valvular Heart Disease: From the Critical Care Cardiology Trials NetworkAnthony P Carnicelli, P Elliott Miller, David D Berg, et al.
The New England Journal of Medicine|October 15, 2010
ARID1A mutations in endometriosis-associated ovarian carcinomasKimberly C Wiegand, Sohrab P Shah, Osama M Al-Agha, et al.
The Lancet. Oncology|July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Martin Köbel, Teri A Longacre, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2019
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S Meagher, Linyuan Wang, Peter F Rambau, et al.
Pageof 7